BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT06085248 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-03-01 → 2024-04-01 3. primary completion date: 2024-02-01 → 2024-03-22 4. enrollment: 44 → 45 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical